Professor K. R. Alexander Knuth is the Chief Executive Officer and Medical Director of the National Center for Cancer Care and Research (NCCCR) and Chairman of Cancer Services at Hamad Medical Corporation in Doha, Qatar. He chairs the Qatar Cancer Research Partnership which is responsible for the implementation of the Qatar National Cancer Framework 2017-2022, involving all clinical, academic and research health partners in Qatar.
Alexander Knuth is Professor Emeritus of the University of Zurich where he held the Chair of Internal Medicine/Oncology from 2003 until 2013. His clinical research focus is on ‘Cancer Immunology and Cancer Immunotherapy’. His pioneering work in human cancer immunology led to the discovery of multiple human cancer antigens including MAGE, the first candidate of the so-called Cancer/Testis (CT) family of antigens. He has authored and co-authored over 250 research articles in peer-reviewed scientific journals, reviews and book chapters and holds over 175 patents in the field of cancer immunology and cancer immunotherapy.
